Denali Therapeutics Berita Eulerpool

Denali Therapeutics Eulerpool News

Denali Therapeutics Berita Saham

Denali Therapeutics diawasi oleh banyak jurnalis dan investor di seluruh dunia. Berita terkini Denali Therapeutics kami rangkum di sini.

• 16 September ·

  Yahoo
  Strength Seen in Denali Therapeutics (DNLI): Can Its 10.1% Jump Turn into More Strength?
• 6 September ·

  Yahoo
  Why Is Kymera Therapeutics (KYMR) Up 10.9% Since Last Earnings Report?
• 5 September ·

  Yahoo
  Myriad (MYGN) Down 4.8% Since Last Earnings Report: Can It Rebound?
• 4 September ·

  Yahoo
  Denali Plans to File for Accelerated Approval of Hunter Syndrome Drug
• 4 September ·

  Yahoo
  Why Is BioMarin (BMRN) Up 5.4% Since Last Earnings Report?
• 4 September ·

  Yahoo
  High-dose Spinraza meets study goal; Top Dyne executives exit
• 4 September ·

  Thefly.com
  Denali Therapeutics price target raised by $4 at BofA, here's why
• 4 September ·

  TipRanks
  Buy Rating Affirmed: FDA’s Endorsement and Promising Data Bolster Denali Therapeutics’s Drug Pipeline
• 4 September ·

  TipRanks
  Denali Therapeutics: Strong Buy on Regulatory Wins and ETV Franchise Progress
• 3 September ·

  Yahoo
  Denali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome)